Thermo Fisher Scientific
The availability of reliable analytical methods and microsampling techniques is crucial for therapeutic drug monitoring (TDM) and for the conduct of clinical PK studies in pediatric research, especially for low birth weight neonates. Sensitivity is of fundamental importance, not only in order to limit blood sample volume but also in order to simplify sample preparation procedures and improve throughput. This workshop will explore analytical challenges and opportunities. Presenter: Giuliana Cangemi, PhD, MSC Istituto Giannina Gaslini Children's Hospital in Genoa, Italy
Adoption of cancer biomarkers in clinical labs has been plagued by the speed with which these biomarkers are discovered and validated for clinical use. Learn what it takes to uncover biomarkers faster for future use in predictive diagnostic. Analyses of lung cancer markers in clinical plasma samples illustrating an advanced workflow automation and improved portability of the developed assays will be discussed in detail. Presenter: Sebastien Gallien, Thermo Fisher Scientific Former Researcher at CRP-Santé LIH Luxembourg Institute of Health
* Required field
To ensure that we are complying with your preferences, we need to confirm permission to send you communications by email.